Krishna Maddula

Title: Innovations by Krishna Maddula

Introduction

Krishna Maddula is an accomplished inventor based in Tucson, Arizona. He has made significant contributions to the field of molecular diagnostics, particularly in the detection of malignancies in melanocytic lesions. With two patents to his name, his work has the potential to impact cancer diagnosis and treatment.

Latest Patents

Maddula's latest patents include methods for determining whether a melanocyte-containing sample, such as a nevus or other pigmented lesion, is benign or a primary melanoma. These methods involve detecting the expression of at least two disclosed genes at the molecular level, such as mRNA, miRNA, or protein, in biological samples obtained from subjects. Additionally, he has developed methods for co-detecting the presence of target messenger RNA (mRNA) and small non-coding RNA, such as miRNA, in a sample. These methods allow for simultaneous detection in a single assay, enhancing the efficiency of molecular diagnostics.

Career Highlights

Throughout his career, Maddula has worked with notable organizations, including Htg Molecular Diagnostics, Inc. and the John Wayne Cancer Institute. His experience in these institutions has contributed to his expertise in molecular diagnostics and cancer research.

Collaborations

Maddula has collaborated with esteemed colleagues, including Bruce Seligmann and Hui Wang, further enriching his research and innovation efforts.

Conclusion

Krishna Maddula's contributions to molecular diagnostics through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in cancer detection and treatment.